Current status and temporal trend of disease burden of thyroid cancer in China from 1990 to 2019
Objective Thyroid cancer has been an increasingly high‐profile public health issue. Comprehensive assessment for its disease burden seems particularly important for understanding health priorities and hinting high‐risk populations. Methods We estimated the age‐sex‐specific thyroid cancer burden and...
Saved in:
Published in | Asia-Pacific journal of clinical oncology Vol. 19; no. 1; pp. 196 - 205 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Australia
Wiley Subscription Services, Inc
01.02.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Objective
Thyroid cancer has been an increasingly high‐profile public health issue. Comprehensive assessment for its disease burden seems particularly important for understanding health priorities and hinting high‐risk populations.
Methods
We estimated the age‐sex‐specific thyroid cancer burden and its temporal trend in China from 1990 to 2019 by following the general methods from the global burden of disease (GBDs) 2019 Study. And Joinpoint regression model, the Cox‐Stuart trend test, and Cochran‐Armitage test were applied for the analysis of temporal and age trend. The Mantel‐Haenszel statistical method was used to compare the gender difference.
Results
From 1990 to 2019, the age‐standardized incidence rate of thyroid cancer in China has almost doubled to 2.05 per 100,000. Although the mortality rate and DALY rate kept leveling off, they presented a downtrend among females, while an upward trend in males. While the average annual percentage changes of those metrics all became deline since 2010 than the previous years. With age advancing, the rates of incidence, mortality, and DALYs for both sexes all presented linear fashion increases, which was particularly typical among males.
Conclusion
Given the serious trend and gender‐age heterogeneity of Chinese thyroid cancer burden, male gender and advanced age may be related to poor prognosis of thyroid cancer, and strengthening primary prevention and exploring the underlying risk factors should be among the top priorities.
Although the incidence of thyroid cancer in Chinese population was lower than the global average, given the huge population base, the burden of thyroid cancer disease in China cannot be ignored, especially the fatal burden among males in China. |
---|---|
AbstractList | Abstract
Objective
Thyroid cancer has been an increasingly high‐profile public health issue. Comprehensive assessment for its disease burden seems particularly important for understanding health priorities and hinting high‐risk populations.
Methods
We estimated the age‐sex‐specific thyroid cancer burden and its temporal trend in China from 1990 to 2019 by following the general methods from the global burden of disease (GBDs) 2019 Study. And Joinpoint regression model, the Cox‐Stuart trend test, and Cochran‐Armitage test were applied for the analysis of temporal and age trend. The Mantel‐Haenszel statistical method was used to compare the gender difference.
Results
From 1990 to 2019, the age‐standardized incidence rate of thyroid cancer in China has almost doubled to 2.05 per 100,000. Although the mortality rate and DALY rate kept leveling off, they presented a downtrend among females, while an upward trend in males. While the average annual percentage changes of those metrics all became deline since 2010 than the previous years. With age advancing, the rates of incidence, mortality, and DALYs for both sexes all presented linear fashion increases, which was particularly typical among males.
Conclusion
Given the serious trend and gender‐age heterogeneity of Chinese thyroid cancer burden, male gender and advanced age may be related to poor prognosis of thyroid cancer, and strengthening primary prevention and exploring the underlying risk factors should be among the top priorities. OBJECTIVEThyroid cancer has been an increasingly high-profile public health issue. Comprehensive assessment for its disease burden seems particularly important for understanding health priorities and hinting high-risk populations. METHODSWe estimated the age-sex-specific thyroid cancer burden and its temporal trend in China from 1990 to 2019 by following the general methods from the global burden of disease (GBDs) 2019 Study. And Joinpoint regression model, the Cox-Stuart trend test, and Cochran-Armitage test were applied for the analysis of temporal and age trend. The Mantel-Haenszel statistical method was used to compare the gender difference. RESULTSFrom 1990 to 2019, the age-standardized incidence rate of thyroid cancer in China has almost doubled to 2.05 per 100,000. Although the mortality rate and DALY rate kept leveling off, they presented a downtrend among females, while an upward trend in males. While the average annual percentage changes of those metrics all became deline since 2010 than the previous years. With age advancing, the rates of incidence, mortality, and DALYs for both sexes all presented linear fashion increases, which was particularly typical among males. CONCLUSIONGiven the serious trend and gender-age heterogeneity of Chinese thyroid cancer burden, male gender and advanced age may be related to poor prognosis of thyroid cancer, and strengthening primary prevention and exploring the underlying risk factors should be among the top priorities. Thyroid cancer has been an increasingly high-profile public health issue. Comprehensive assessment for its disease burden seems particularly important for understanding health priorities and hinting high-risk populations. We estimated the age-sex-specific thyroid cancer burden and its temporal trend in China from 1990 to 2019 by following the general methods from the global burden of disease (GBDs) 2019 Study. And Joinpoint regression model, the Cox-Stuart trend test, and Cochran-Armitage test were applied for the analysis of temporal and age trend. The Mantel-Haenszel statistical method was used to compare the gender difference. From 1990 to 2019, the age-standardized incidence rate of thyroid cancer in China has almost doubled to 2.05 per 100,000. Although the mortality rate and DALY rate kept leveling off, they presented a downtrend among females, while an upward trend in males. While the average annual percentage changes of those metrics all became deline since 2010 than the previous years. With age advancing, the rates of incidence, mortality, and DALYs for both sexes all presented linear fashion increases, which was particularly typical among males. Given the serious trend and gender-age heterogeneity of Chinese thyroid cancer burden, male gender and advanced age may be related to poor prognosis of thyroid cancer, and strengthening primary prevention and exploring the underlying risk factors should be among the top priorities. Objective Thyroid cancer has been an increasingly high‐profile public health issue. Comprehensive assessment for its disease burden seems particularly important for understanding health priorities and hinting high‐risk populations. Methods We estimated the age‐sex‐specific thyroid cancer burden and its temporal trend in China from 1990 to 2019 by following the general methods from the global burden of disease (GBDs) 2019 Study. And Joinpoint regression model, the Cox‐Stuart trend test, and Cochran‐Armitage test were applied for the analysis of temporal and age trend. The Mantel‐Haenszel statistical method was used to compare the gender difference. Results From 1990 to 2019, the age‐standardized incidence rate of thyroid cancer in China has almost doubled to 2.05 per 100,000. Although the mortality rate and DALY rate kept leveling off, they presented a downtrend among females, while an upward trend in males. While the average annual percentage changes of those metrics all became deline since 2010 than the previous years. With age advancing, the rates of incidence, mortality, and DALYs for both sexes all presented linear fashion increases, which was particularly typical among males. Conclusion Given the serious trend and gender‐age heterogeneity of Chinese thyroid cancer burden, male gender and advanced age may be related to poor prognosis of thyroid cancer, and strengthening primary prevention and exploring the underlying risk factors should be among the top priorities. Although the incidence of thyroid cancer in Chinese population was lower than the global average, given the huge population base, the burden of thyroid cancer disease in China cannot be ignored, especially the fatal burden among males in China. |
Author | Zhang, Meng‐Ni Xie, Juan Li, Mao‐Ting Zhu, Hong Liang, Xiao‐Yu Zhi, Xin‐Yue Yan, Qiu‐Yu |
Author_xml | – sequence: 1 givenname: Meng‐Ni surname: Zhang fullname: Zhang, Meng‐Ni organization: Nutrition and Public Health – sequence: 2 givenname: Xiao‐Yu surname: Liang fullname: Liang, Xiao‐Yu organization: Tianjin Medical University General Hospital – sequence: 3 givenname: Mao‐Ting surname: Li fullname: Li, Mao‐Ting organization: Nutrition and Public Health – sequence: 4 givenname: Xin‐Yue surname: Zhi fullname: Zhi, Xin‐Yue organization: Nutrition and Public Health – sequence: 5 givenname: Qiu‐Yu surname: Yan fullname: Yan, Qiu‐Yu organization: Nutrition and Public Health – sequence: 6 givenname: Hong surname: Zhu fullname: Zhu, Hong organization: Nutrition and Public Health – sequence: 7 givenname: Juan orcidid: 0000-0002-7841-6749 surname: Xie fullname: Xie, Juan email: xiejuan@tmu.edu.cn organization: Nutrition and Public Health |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35692103$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kMFq3DAQhkXZ0N1se-kDFEEvJbCJZFmSdVxMmyYE9pK7MpbGxIstbSWbsm8fbzbNoYfOZYaZj4_hvySLEAMS8oWzaz7XDexdvOaiYuwDWXFdio2WSizeZymX5DLnPWPCFIZ_JEshlSk4EyvyVE8pYRhpHmGcMoXg6YjDISbo6ThfPI0t9V1GyEibKXkMp834fEyx89RBcJhoF2j93AWgbYoD5cYwOkZaMG4-kYsW-oyf3_qaPP788Vj_2jzsbu_q7cPGCanZpnCofdlKLHQJ2pUKwEjfyLZRjfIaGlZVSnooVQPYaGfAGyNEq0teIQqxJt_P2kOKvyfMox267LDvIWCcsi2UlqZSiqsZ_fYPuo9TCvNzttBaaCZEeRJenSmXYs4JW3tI3QDpaDmzp9jtKXb7GvsMf31TTs2A_h39m_MM8DPwp-vx-B-V3d7Xu7P0BQ3ijSM |
CitedBy_id | crossref_primary_10_22141_2224_0721_20_3_2024_1387 crossref_primary_10_1016_j_heliyon_2023_e22490 crossref_primary_10_1186_s13044_024_00191_x crossref_primary_10_2147_IJGM_S461708 crossref_primary_10_1002_jum_16429 |
Cites_doi | 10.1002/ijc.33298 10.2217/fon.10.127 10.1038/s41574-019-0263-x 10.1038/s41598-020-79176-3 10.1111/j.1365-2184.2007.00471.x 10.1016/S0140-6736(12)60278-5 10.1177/1010539512436874 10.1001/jamaoncol.2015.1426 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z 10.1001/jamaoncol.2015.0735 10.1089/thy.2017.0102 10.1016/S2213-8587(21)00083-8 10.3322/caac.21262 10.1093/eurpub/ckq120 10.1016/j.jncc.2022.02.002 10.1001/jamaoncol.2021.6987 10.1056/NEJMp1604412 10.3322/caac.21439 10.1016/S1470-2045(19)30339-0 10.1002/cncr.33392 10.1056/NEJMp1409841 10.1016/S0140-6736(20)30977-6 10.1002/sim.3733 10.1089/thy.2015.0613 10.1177/0962280211406424 10.1007/s10552-018-1023-2 10.1158/1055-9965.EPI-08-0976 10.3389/fendo.2021.655608 10.1001/jamaoncol.2019.2996 10.1093/aje/kwp354 10.1016/j.ypmed.2019.105849 10.3322/caac.21660 10.1089/thy.2016.0100 10.1111/j.1365-2265.2006.02605.x 10.12659/MSM.892035 10.1016/S0140-6736(19)30427-1 10.1146/annurev-med-061512-105739 10.1002/cncr.22754 10.1016/S1470-2045(20)30073-5 10.1016/S0140-6736(20)30925-9 10.1111/cen.13254 10.1002/cncr.29747 10.1097/00130404-200503000-00006 |
ContentType | Journal Article |
Copyright | 2022 John Wiley & Sons Australia, Ltd. 2023 John Wiley & Sons Australia, Ltd. |
Copyright_xml | – notice: 2022 John Wiley & Sons Australia, Ltd. – notice: 2023 John Wiley & Sons Australia, Ltd. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7TO H94 7X8 |
DOI | 10.1111/ajco.13800 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Oncogenes and Growth Factors Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Oncogenes and Growth Factors Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE Oncogenes and Growth Factors Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health |
EISSN | 1743-7563 |
EndPage | 205 |
ExternalDocumentID | 10_1111_ajco_13800 35692103 AJCO13800 |
Genre | article Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GrantInformation_xml | – fundername: National Natural Science Foundation of China funderid: 81602922 – fundername: National Natural Science Foundation of China grantid: 81602922 |
GroupedDBID | --- .3N .GA 05W 0R~ 10A 1OC 23N 31~ 33P 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFZJQ AHBTC AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM EBD EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZ~ IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D Q.N Q11 QB0 R.K ROL RX1 SUPJJ SV3 TEORI TUS UB1 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXSBR XG1 ZZTAW ~IA ~WT ACXME CGR CUY CVF ECM EIF NPM AAYXX CITATION 7TO H94 7X8 |
ID | FETCH-LOGICAL-c3570-2ce7d4f5e274a7c46aa95db5fb6b6d7ab08865da46baeb7c9ad9933f7418ee33 |
IEDL.DBID | DR2 |
ISSN | 1743-7555 |
IngestDate | Fri Aug 16 04:05:21 EDT 2024 Fri Sep 13 04:17:31 EDT 2024 Fri Aug 23 01:04:27 EDT 2024 Thu May 23 23:32:32 EDT 2024 Sat Aug 24 01:07:59 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | cancer burden thyroid cancer epidemiological distribution age-sex distribution disability-adjusted life years |
Language | English |
License | 2022 John Wiley & Sons Australia, Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3570-2ce7d4f5e274a7c46aa95db5fb6b6d7ab08865da46baeb7c9ad9933f7418ee33 |
Notes | These authors contributed equally to this study. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-7841-6749 |
PMID | 35692103 |
PQID | 2773703343 |
PQPubID | 2045194 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_2675986616 proquest_journals_2773703343 crossref_primary_10_1111_ajco_13800 pubmed_primary_35692103 wiley_primary_10_1111_ajco_13800_AJCO13800 |
PublicationCentury | 2000 |
PublicationDate | February 2023 2023-Feb 2023-02-00 20230201 |
PublicationDateYYYYMMDD | 2023-02-01 |
PublicationDate_xml | – month: 02 year: 2023 text: February 2023 |
PublicationDecade | 2020 |
PublicationPlace | Australia |
PublicationPlace_xml | – name: Australia – name: Chichester |
PublicationTitle | Asia-Pacific journal of clinical oncology |
PublicationTitleAlternate | Asia Pac J Clin Oncol |
PublicationYear | 2023 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2021; 9 2015; 1 2018; 29 2017; 86 2019; 5 2021; 148 2017; 27 2021; 127 2020; 16 2016; 122 2014; 371 2020; 10 2019; 129S 2021; 71 2014; 23 1959; 22 2014; 65 2009; 28 2018; 68 2001; 81 2000; 19 2015; 27 2021; 12 2019; 20 2020; 396 2006; 65 2007; 110 2022; 8 2015; 65 2015; 21 2016; 375 2011; 21 2007; 40 2022; 2 2020; 21 2010; 171 2019; 394 2012; 379 2016; 26 2003; 63 2005; 11 2010; 6 2009; 18 2007; 26 e_1_2_12_4_1 e_1_2_12_6_1 e_1_2_12_19_1 e_1_2_12_2_1 e_1_2_12_17_1 e_1_2_12_38_1 Xu X (e_1_2_12_39_1) 2003; 63 e_1_2_12_20_1 e_1_2_12_41_1 e_1_2_12_22_1 e_1_2_12_43_1 e_1_2_12_24_1 e_1_2_12_45_1 e_1_2_12_26_1 e_1_2_12_49_1 e_1_2_12_33_1 e_1_2_12_35_1 e_1_2_12_37_1 e_1_2_12_14_1 e_1_2_12_12_1 e_1_2_12_8_1 Mantel N (e_1_2_12_28_1) 1959; 22 e_1_2_12_10_1 e_1_2_12_50_1 e_1_2_12_3_1 e_1_2_12_5_1 e_1_2_12_18_1 Su XH (e_1_2_12_47_1) 2007; 26 e_1_2_12_16_1 e_1_2_12_42_1 e_1_2_12_21_1 e_1_2_12_44_1 e_1_2_12_23_1 e_1_2_12_46_1 e_1_2_12_25_1 e_1_2_12_48_1 Guan H (e_1_2_12_31_1) 2001; 81 e_1_2_12_40_1 e_1_2_12_27_1 e_1_2_12_29_1 e_1_2_12_30_1 e_1_2_12_32_1 e_1_2_12_34_1 e_1_2_12_36_1 e_1_2_12_15_1 e_1_2_12_13_1 e_1_2_12_11_1 e_1_2_12_7_1 e_1_2_12_51_1 e_1_2_12_9_1 |
References_xml | – volume: 27 start-page: NP223 issue: 2 year: 2015 end-page: NP229 article-title: Increasing incidence of thyroid cancer in Shanghai, China, 1983–2007 publication-title: Asia Pac J Public Health – volume: 19 start-page: 335 issue: 3 year: 2000 end-page: 351 article-title: Permutation tests for Joinpoint regression with applications to cancer rates publication-title: Stat Med – volume: 23 start-page: 218 issue: 3 year: 2014 end-page: 243 article-title: On the power of the Cochran‐Armitage test for trend in the presence of misclassification publication-title: Stat Methods Med Res – volume: 22 start-page: 719 issue: 4 year: 1959 end-page: 748 article-title: Statistical aspects of the analysis of data from retrospective studies of disease publication-title: J Natl Cancer Inst – volume: 2 start-page: 1 issue: 1 year: 2022 end-page: 9 article-title: Cancer incidence and mortality in China, 2016 publication-title: J Natl Cancer Center – volume: 1 start-page: 425 issue: 4 year: 2015 end-page: 427 article-title: Novel methods for measuring global cancer burden: implications for global cancer control publication-title: JAMA Oncol – volume: 1 start-page: 505 issue: 4 year: 2015 end-page: 527 article-title: The global burden of cancer 2013 publication-title: JAMA oncology – volume: 394 start-page: 1145 issue: 10204 year: 2019 end-page: 1158 article-title: Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the global burden of disease study 2017 publication-title: Lancet (London, England) – volume: 21 start-page: 573 issue: 5 year: 2011 end-page: 577 article-title: The validity of the mortality to incidence ratio as a proxy for site‐specific cancer survival publication-title: Eur J Public Health – volume: 26 start-page: 1541 issue: 11 year: 2016 end-page: 1552 article-title: Systematic review of trends in the incidence rates of thyroid cancer publication-title: Thyroid – volume: 27 start-page: 751 issue: 6 year: 2017 end-page: 756 article-title: Updated American joint committee on cancer/tumor‐node‐metastasis staging system for differentiated and anaplastic thyroid cancer (eighth edition): what changed and why? publication-title: Thyroid – volume: 5 start-page: 1749 issue: 12 year: 2019 end-page: 1768 article-title: Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability‐adjusted life‐years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study publication-title: JAMA oncology – volume: 12 year: 2021 article-title: Extent of surgery and the prognosis of unilateral papillary thyroid microcarcinoma publication-title: Front Endocrinol (Lausanne) – volume: 65 start-page: 364 issue: 3 year: 2006 end-page: 368 article-title: The BRAF mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma publication-title: Clin Endocrinol (Oxf) – volume: 171 start-page: 242 issue: 2 year: 2010 end-page: 252 article-title: Nonradiation risk factors for thyroid cancer in the US radiologic technologists study publication-title: Am J Epidemiol – volume: 28 start-page: 3670 issue: 29 year: 2009 end-page: 3682 article-title: Estimating average annual per cent change in trend analysis publication-title: Stat Med – volume: 86 start-page: 438 issue: 3 year: 2017 end-page: 443 article-title: Optimal cut‐off age in the TNM staging system of differentiated thyroid cancer: is 55 years better than 45 years? publication-title: Clin Endocrinol (Oxf) – volume: 148 start-page: 1106 issue: 5 year: 2021 end-page: 1114 article-title: Screening and the epidemic of thyroid cancer in China: an analysis of national representative inpatient and commercial insurance databases publication-title: Int J Cancer – volume: 81 start-page: 457 issue: 8 year: 2001 end-page: 458 article-title: Comparative epidemiological study on thyroid cancer in areas with different iodine intakes publication-title: Zhonghua Yi Xue Za Zhi – volume: 20 start-page: 1211 issue: 9 year: 2019 end-page: 1225 article-title: The global burden of childhood and adolescent cancer in 2017: an analysis of the global burden of disease study 2017 publication-title: The Lancet Oncology – volume: 396 start-page: 1160 issue: 10258 year: 2020 end-page: 1203 article-title: Global age‐sex‐specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the global burden of disease study 2019 publication-title: Lancet (London, England) – volume: 129S year: 2019 article-title: Mortality‐to‐incidence ratios by US congressional district: implications for epidemiologic, dissemination and implementation research, and public health policy publication-title: Prev Med – volume: 9 start-page: 330 issue: 6 year: 2021 end-page: 332 article-title: Mapping overdiagnosis of thyroid cancer in China publication-title: Lancet Diabetes Endocrinol – volume: 18 start-page: 1092 issue: 4 year: 2009 end-page: 1100 article-title: Gender is an age‐specific effect modifier for papillary cancers of the thyroid gland publication-title: Cancer Epidemiol Biomarkers Prev – volume: 26 start-page: 1125 issue: 8 year: 2016 end-page: 1130 article-title: Iodine status and prevalence of thyroid disorders after introduction of mandatory universal salt iodization for 16 years in china: a cross‐sectional study in 10 cities publication-title: Thyroid – volume: 16 start-page: 17 issue: 1 year: 2020 end-page: 29 article-title: Geographic influences in the global rise of thyroid cancer publication-title: Nat Rev Endocrinol – volume: 11 start-page: 113 issue: 2 year: 2005 end-page: 121 article-title: Induction of thyroid papillary carcinoma cell proliferation by estrogen is associated with an altered expression of Bcl‐xL publication-title: Cancer J – volume: 71 start-page: 209 issue: 3 year: 2021 end-page: 249 article-title: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J Clin – volume: 68 start-page: 55 issue: 1 year: 2018 end-page: 63 article-title: Differentiated and anaplastic thyroid carcinoma: major changes in the American joint committee on cancer eighth edition cancer staging manual publication-title: CA Cancer J Clin – volume: 21 start-page: 283 year: 2015 end-page: 291 article-title: Obesity and risk of thyroid cancer: evidence from a meta‐analysis of 21 observational studies publication-title: Med Sci Monit – volume: 63 start-page: 4561 issue: 15 year: 2003 end-page: 4567 article-title: High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines publication-title: Cancer Res – volume: 65 start-page: 125 year: 2014 end-page: 137 article-title: Thyroid cancer publication-title: Annu Rev Med – volume: 6 start-page: 1771 issue: 11 year: 2010 end-page: 1779 article-title: Thyroid cancer gender disparity publication-title: Future Oncol – volume: 110 start-page: 38 issue: 1 year: 2007 end-page: 46 article-title: Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid: a meta‐analysis publication-title: Cancer – volume: 40 start-page: 921 issue: 6 year: 2007 end-page: 935 article-title: Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor‐ERK pathway publication-title: Cell Prolif – volume: 26 start-page: 67 year: 2007 end-page: 69 publication-title: Chinese Journal of Endemiology. – volume: 375 start-page: 614 issue: 7 year: 2016 end-page: 617 article-title: Worldwide thyroid‐cancer epidemic? The increasing impact of overdiagnosis publication-title: N Engl J Med – volume: 127 start-page: 1448 issue: 9 year: 2021 end-page: 1458 article-title: Associations between artificial light at night and risk for thyroid cancer: a large US cohort study publication-title: Cancer – volume: 10 issue: 1 year: 2020 article-title: National burden of cancer in Italy, 1990–2017: a systematic analysis for the global burden of disease study 2017 publication-title: Sci Rep – volume: 371 start-page: 1765 issue: 19 year: 2014 end-page: 1767 article-title: Korea's thyroid‐cancer “epidemic”–screening and overdiagnosis publication-title: N Engl J Med – volume: 379 start-page: 805 issue: 9818 year: 2012 end-page: 814 article-title: Trends in access to health services and financial protection in China between 2003 and 2011: a cross‐sectional study publication-title: Lancet (London, England) – volume: 8 start-page: 420 issue: 3 year: 2022 end-page: 444 article-title: Cancer incidence, mortality, years of life lost, years lived with disability, and disability‐adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019 publication-title: JAMA Oncology – volume: 396 start-page: 1204 issue: 10258 year: 2020 end-page: 1222 article-title: Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019 publication-title: Lancet (London, England) – volume: 122 start-page: 486 issue: 3 year: 2016 end-page: 487 article-title: Conceptual considerations and methodological recommendations for the use of the mortality‐to‐incidence ratio in time‐lagged, ecological‐level analysis for public health systems‐oriented cancer research publication-title: Cancer – volume: 29 start-page: 465 issue: 4‐5 year: 2018 end-page: 473 article-title: An update in international trends in incidence rates of thyroid cancer, 1973–2007 publication-title: Cancer Causes Control – volume: 21 start-page: e342 issue: 7 year: 2020 end-page: e349 article-title: Cancer registration in China and its role in cancer prevention and control publication-title: The Lancet Oncology – volume: 65 start-page: 87 issue: 2 year: 2015 end-page: 108 article-title: Global cancer statistics, 2012 publication-title: CA Cancer J Clin – volume: 1 start-page: 425 issue: 4 year: 2015 end-page: 427 article-title: Novel methods for measuring global cancer burden: implications for global cancer control publication-title: JAMA Oncology – ident: e_1_2_12_45_1 doi: 10.1002/ijc.33298 – ident: e_1_2_12_33_1 doi: 10.2217/fon.10.127 – ident: e_1_2_12_2_1 doi: 10.1038/s41574-019-0263-x – ident: e_1_2_12_16_1 doi: 10.1038/s41598-020-79176-3 – ident: e_1_2_12_42_1 doi: 10.1111/j.1365-2184.2007.00471.x – ident: e_1_2_12_46_1 doi: 10.1016/S0140-6736(12)60278-5 – ident: e_1_2_12_30_1 doi: 10.1177/1010539512436874 – ident: e_1_2_12_17_1 doi: 10.1001/jamaoncol.2015.1426 – ident: e_1_2_12_24_1 doi: 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z – ident: e_1_2_12_8_1 doi: 10.1001/jamaoncol.2015.0735 – ident: e_1_2_12_36_1 doi: 10.1089/thy.2017.0102 – ident: e_1_2_12_43_1 doi: 10.1016/S2213-8587(21)00083-8 – ident: e_1_2_12_4_1 doi: 10.3322/caac.21262 – ident: e_1_2_12_20_1 doi: 10.1093/eurpub/ckq120 – ident: e_1_2_12_5_1 doi: 10.1016/j.jncc.2022.02.002 – ident: e_1_2_12_12_1 doi: 10.1001/jamaoncol.2021.6987 – volume: 63 start-page: 4561 issue: 15 year: 2003 ident: e_1_2_12_39_1 article-title: High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines publication-title: Cancer Res contributor: fullname: Xu X – ident: e_1_2_12_7_1 doi: 10.1056/NEJMp1604412 – ident: e_1_2_12_37_1 doi: 10.3322/caac.21439 – ident: e_1_2_12_15_1 doi: 10.1016/S1470-2045(19)30339-0 – ident: e_1_2_12_50_1 doi: 10.1002/cncr.33392 – ident: e_1_2_12_51_1 doi: 10.1001/jamaoncol.2015.1426 – ident: e_1_2_12_6_1 doi: 10.1056/NEJMp1409841 – ident: e_1_2_12_11_1 doi: 10.1016/S0140-6736(20)30977-6 – ident: e_1_2_12_23_1 doi: 10.1002/sim.3733 – ident: e_1_2_12_29_1 doi: 10.1089/thy.2015.0613 – ident: e_1_2_12_27_1 doi: 10.1177/0962280211406424 – volume: 22 start-page: 719 issue: 4 year: 1959 ident: e_1_2_12_28_1 article-title: Statistical aspects of the analysis of data from retrospective studies of disease publication-title: J Natl Cancer Inst contributor: fullname: Mantel N – ident: e_1_2_12_9_1 doi: 10.1007/s10552-018-1023-2 – ident: e_1_2_12_34_1 doi: 10.1158/1055-9965.EPI-08-0976 – ident: e_1_2_12_21_1 doi: 10.1001/jamaoncol.2021.6987 – volume: 26 start-page: 67 year: 2007 ident: e_1_2_12_47_1 publication-title: Chinese Journal of Endemiology. contributor: fullname: Su XH – ident: e_1_2_12_26_1 doi: 10.3389/fendo.2021.655608 – ident: e_1_2_12_22_1 doi: 10.1001/jamaoncol.2019.2996 – ident: e_1_2_12_49_1 doi: 10.1093/aje/kwp354 – ident: e_1_2_12_18_1 doi: 10.1016/j.ypmed.2019.105849 – ident: e_1_2_12_3_1 doi: 10.3322/caac.21660 – ident: e_1_2_12_32_1 doi: 10.1089/thy.2016.0100 – ident: e_1_2_12_38_1 doi: 10.1111/j.1365-2265.2006.02605.x – ident: e_1_2_12_48_1 doi: 10.12659/MSM.892035 – ident: e_1_2_12_14_1 doi: 10.1016/S0140-6736(19)30427-1 – ident: e_1_2_12_44_1 doi: 10.1146/annurev-med-061512-105739 – ident: e_1_2_12_40_1 doi: 10.1002/cncr.22754 – volume: 81 start-page: 457 issue: 8 year: 2001 ident: e_1_2_12_31_1 article-title: Comparative epidemiological study on thyroid cancer in areas with different iodine intakes publication-title: Zhonghua Yi Xue Za Zhi contributor: fullname: Guan H – ident: e_1_2_12_13_1 doi: 10.1016/S1470-2045(20)30073-5 – ident: e_1_2_12_10_1 doi: 10.1016/S0140-6736(20)30925-9 – ident: e_1_2_12_35_1 doi: 10.1111/cen.13254 – ident: e_1_2_12_19_1 doi: 10.1002/cncr.29747 – ident: e_1_2_12_41_1 doi: 10.1097/00130404-200503000-00006 – ident: e_1_2_12_25_1 |
SSID | ssj0039291 |
Score | 2.332785 |
Snippet | Objective
Thyroid cancer has been an increasingly high‐profile public health issue. Comprehensive assessment for its disease burden seems particularly... Thyroid cancer has been an increasingly high-profile public health issue. Comprehensive assessment for its disease burden seems particularly important for... Abstract Objective Thyroid cancer has been an increasingly high‐profile public health issue. Comprehensive assessment for its disease burden seems particularly... ObjectiveThyroid cancer has been an increasingly high‐profile public health issue. Comprehensive assessment for its disease burden seems particularly important... OBJECTIVEThyroid cancer has been an increasingly high-profile public health issue. Comprehensive assessment for its disease burden seems particularly important... |
SourceID | proquest crossref pubmed wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 196 |
SubjectTerms | Age age‐sex distribution cancer burden China - epidemiology Cost of Illness disability‐adjusted life years epidemiological distribution Female Gender Gender differences Humans Incidence Male Males Mortality Public health Quality-Adjusted Life Years Risk factors Thyroid cancer Thyroid Neoplasms - epidemiology |
Title | Current status and temporal trend of disease burden of thyroid cancer in China from 1990 to 2019 |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fajco.13800 https://www.ncbi.nlm.nih.gov/pubmed/35692103 https://www.proquest.com/docview/2773703343/abstract/ https://search.proquest.com/docview/2675986616 |
Volume | 19 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB4WD-LF92N1lYiehC7tpkm24GURRRZWQRS8SE3SFHzQym734q93po_VVRD0VtqEtJnMzDfNzBeAY59bLdHTeIKL1Ast114UucRLMZSQPZWmYZ8KhUdX8vIuHN6L-xacNrUwFT_E7IcbaUZpr0nBtZl8UXL9bPNuwBHwoAEmJj1CRDcz7ijy-0FVDck9JYSouUkpjeez67w3-gEx5xFr6XIuVuChedkq0-SlOy1M175_43H879eswnKNRdmgWjxr0HLZOiyO6t32DXisyZsYVR1NJ0xnCauprF5ZQcm0LE9ZvcXDTFkQQXdQ9uP8KWGWVtSYPWWsPKWbUSkLC9AxsSJnCAmiTbi9OL89u_TqExk8y4XyvZ51KglT4TCW1cqGUutIJEakRhqZKG3QZkmR6FAa7YyykU4Q__CUKHKc43wLFrI8cztAg2iEFwYBhgyF7Wk_cAh9fBlZ5wfWb8NRI5j4reLdiJt4heYqLueqDZ1GZnGte5O4pxRHO8ZD3obD2WPUGtoK0ZnLp9gG46Soj9hEtmG7kvVsGC5khIEw9j4pJfbL-PFgeHZdXu3-pfEeLNGp9VXydwcWivHU7SO2KcxBuYY_AJfY8Z4 |
link.rule.ids | 315,786,790,1382,27957,27958,46329,46753 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fT9swED4NkMZe-A0rMDAaT0ipkjq2ySNCQx1QkFAn8RZsx5EKKJna9GV_PXeOW8YmIW1vUWLLiu_O95199xngOOZWS_Q0keCijFLLdZRlrohKDCVkT5VlekqFwoMb2f-RXt6L-5CbQ7UwLT_EfMONLMOv12TgtCH9m5XrR1t3E46IZwGW0N6Fj6ju5uxR5PmTth6SR0oIEdhJKZHnte9bf_QXyHyLWb3TuVhtb1adeK5CyjV56k4b07W__mBy_O__WYOVAEfZWas_6_DBVRvwcRAO3DfhIfA3MSo8mk6YrgoW2KyeWUP5tKwuWTjlYcbXRNAbFP-4HhXMklKN2ahi_qJuRtUsLEHfxJqaISrItmB48W143o_CpQyR5ULFUc86VaSlcBjOamVTqXUmCiNKI40slDa4bElR6FQa7YyymS4QAvGSWHKc43wbFqu6cp-BBtGIMAxiDJkK29Nx4hD9xDKzLk5s3IGvM8nkP1vqjXwWstBc5X6uOrA_E1oezG-S95TiuJTxlHfgaP4ZDYdOQ3Tl6im2QY3JThGeyA7stMKeD8OFzDAWxt4nXmTvjJ-fXZ7f-qfdf2l8CMv94eA6v_5-c7UHn-gS-zYXfB8Wm_HUfUGo05gDr9AvzF71wA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS91AEB68gPhSa70dq3aLfRJySLI3A30R7UFttVIUfJG4VzhWEjnmvPjrO5vL8VIQ9C0ku2yyM7PzTXbmW4BvMTVKoKeJOOU-YoaqKMucjTyGEiKV3rPdUCh8cioOL9jxJb-cgu9dLUzDDzH54RYso16vg4HfWf_EyNWNKfsJRcAzDbNM0DTo9MGfCXlUcPxJUw5JI8k5b8lJQx7PY9_n7ug_jPkcstY-Z7AAV93bNqkmf_vjSvfNwwsix_d-zkf40IJRstdozyJMueITzJ202-1LcN2yN5FQdjS-J6qwpOWyuiVVyKYlpSftHg_RdUVEuIPCH5VDS0xQqREZFqQ-ppuEWhaSoGciVUkQE2TLcD74cb5_GLVHMkSGchlHqXHSMs8dBrNKGiaUyrjV3GuhhZVK46IluFVMaOW0NJmyCICoDxw5zlG6AjNFWbg1CIMoxBcaEYZg3KQqThxin1hkxsWJiXuw3Qkmv2uIN_IuYAlzlddz1YONTmZ5a3z3eSolxYWMMtqDr5PHaDZhL0QVrhxjGwyUsl0EJ6IHq42sJ8NQLjKMhLH3Ti2xV8bP9473f9dX629p_AXmzg4G-a-j05-fYT6cYN8kgm_ATDUau03EOZXeqtX5H_D_9G8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Current+status+and+temporal+trend+of+disease+burden+of+thyroid+cancer+in+China+from+1990+to+2019&rft.jtitle=Asia-Pacific+journal+of+clinical+oncology&rft.au=Zhang%2C+Meng-Ni&rft.au=Liang%2C+Xiao-Yu&rft.au=Li%2C+Mao-Ting&rft.au=Zhi%2C+Xin-Yue&rft.date=2023-02-01&rft.eissn=1743-7563&rft.volume=19&rft.issue=1&rft.spage=196&rft_id=info:doi/10.1111%2Fajco.13800&rft_id=info%3Apmid%2F35692103&rft.externalDocID=35692103 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1743-7555&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1743-7555&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1743-7555&client=summon |